Research Projects Supported by the University of California, San Francisco-Stanford Center of Excellence in Regulatory Science and Innovation

被引：5
|
作者：
Giacomini, Kathleen M. [1 ]
Lin, Lawrence [1 ]
Altman, Russ B. [2 ,3 ,4 ]
机构：
[1] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA
[2] Stanford Univ, Dept Genet, Stanford, CA 94305 USA
[3] Stanford Univ, Sch Engn, Dept Bioengn, Stanford, CA 94305 USA
[4] Stanford Univ, Sch Med, Dept Bioengn, Stanford, CA 94305 USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2019年 / 105卷 / 04期
关键词：
D O I：
10.1002/cpt.1308
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
A critical mission of the US Food and Drug Administration ( FDA) is to protect public health by ensuring the safety and efficacy of medical products. With the plethora of innovative new medical products under development and a growing body of emerging research, such as natural language processing, artificial intelligence, and research in the human microbiome, the FDA has increasingly sponsored collaborative research with academic institutions, including Centers of Excellence in Regulatory Science and Innovation ( CERSI).
引用
收藏
页码：815 / 818
页数：4
相关论文
共 50 条
12345